1. Home
  2. PCVX vs BIRK Comparison

PCVX vs BIRK Comparison

Compare PCVX & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • BIRK
  • Stock Information
  • Founded
  • PCVX 2013
  • BIRK 1774
  • Country
  • PCVX United States
  • BIRK United Kingdom
  • Employees
  • PCVX N/A
  • BIRK N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • BIRK
  • Sector
  • PCVX Health Care
  • BIRK
  • Exchange
  • PCVX Nasdaq
  • BIRK Nasdaq
  • Market Cap
  • PCVX 4.4B
  • BIRK 8.8B
  • IPO Year
  • PCVX 2020
  • BIRK 2023
  • Fundamental
  • Price
  • PCVX $33.27
  • BIRK $49.03
  • Analyst Decision
  • PCVX Strong Buy
  • BIRK Strong Buy
  • Analyst Count
  • PCVX 10
  • BIRK 10
  • Target Price
  • PCVX $136.50
  • BIRK $69.00
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • BIRK 1.9M
  • Earning Date
  • PCVX 08-05-2025
  • BIRK 08-28-2025
  • Dividend Yield
  • PCVX N/A
  • BIRK N/A
  • EPS Growth
  • PCVX N/A
  • BIRK 152.58
  • EPS
  • PCVX N/A
  • BIRK 1.45
  • Revenue
  • PCVX N/A
  • BIRK $2,114,754,647.00
  • Revenue This Year
  • PCVX N/A
  • BIRK $19.19
  • Revenue Next Year
  • PCVX N/A
  • BIRK $15.95
  • P/E Ratio
  • PCVX N/A
  • BIRK $33.79
  • Revenue Growth
  • PCVX N/A
  • BIRK 19.89
  • 52 Week Low
  • PCVX $27.66
  • BIRK $40.56
  • 52 Week High
  • PCVX $121.06
  • BIRK $64.78
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 46.99
  • BIRK 34.73
  • Support Level
  • PCVX $32.00
  • BIRK $48.51
  • Resistance Level
  • PCVX $34.63
  • BIRK $50.28
  • Average True Range (ATR)
  • PCVX 1.31
  • BIRK 1.35
  • MACD
  • PCVX -0.08
  • BIRK -0.46
  • Stochastic Oscillator
  • PCVX 37.46
  • BIRK 12.19

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

Share on Social Networks: